Literature DB >> 9476760

A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls.

P Strickland1, R Morriss, A Wearden, B Deakin.   

Abstract

BACKGROUND: Previous studies reporting cortisol hyposecretion in chronic fatigue syndrome may have been confounded by venepuncture, fasting and hospitalisation.
METHODS: Morning and evening salivary cortisol were obtained on consecutive days in the first 3 days of the menstrual cycle and compared in three samples of women taking no medication and matched for age: 14 patients with chronic fatigue syndrome, 26 community cases of ICD-10 current depressive episodes and 131 healthy community controls.
RESULTS: The mean evening cortisol was significantly lower in the chronic fatigue syndrome patients compared to controls with depression (P = 0.02) and healthy controls (P = 0.005). Chronic fatigue syndrome patients without psychiatric disorder had significantly lower morning salivary cortisols compared to controls (P = 0.009).
CONCLUSION: Chronic fatigue syndrome patients display cortisol hyposecretion in saliva as well as plasma compared to patients with depression and healthy controls. LIMITATIONS: Small samples of female patients with cortisol estimated at only two time points in the day. Cortisol secretion may be secondary to other neurotransmitter abnormalities or other physiological or lifestyle factors in chronic fatigue syndrome patients. CLINICAL RELEVANCE: Chronic fatigue syndrome is biochemically distinct from community depression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9476760     DOI: 10.1016/s0165-0327(97)00134-1

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  9 in total

1.  Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome.

Authors:  B A Corbett; S P Mendoza; C L Baym; S A Bunge; S Levine
Journal:  Psychoneuroendocrinology       Date:  2008-05-19       Impact factor: 4.905

2.  How stable are diurnal cortisol activity indices in healthy individuals? Evidence from three multi-wave studies.

Authors:  Kharah M Ross; Michael L M Murphy; Emma K Adam; Edith Chen; Gregory E Miller
Journal:  Psychoneuroendocrinology       Date:  2013-09-21       Impact factor: 4.905

Review 3.  Neuroendocrine and immune contributors to fatigue.

Authors:  Marni N Silverman; Christine M Heim; Urs M Nater; Andrea H Marques; Esther M Sternberg
Journal:  PM R       Date:  2010-05       Impact factor: 2.298

Review 4.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

5.  Comparing cortisol, stress, and sensory sensitivity in children with autism.

Authors:  Blythe A Corbett; Clayton W Schupp; Seymour Levine; Sally Mendoza
Journal:  Autism Res       Date:  2009-02       Impact factor: 5.216

6.  Investigation of cortisol dynamics in human sweat using a graphene-based wireless mHealth system.

Authors:  Rebeca M Torrente-Rodríguez; Jiaobing Tu; Yiran Yang; Jihong Min; Minqiang Wang; Yu Song; You Yu; Changhao Xu; Cui Ye; Waguih William IsHak; Wei Gao
Journal:  Matter       Date:  2020-02-26

Review 7.  Adrenal fatigue does not exist: a systematic review.

Authors:  Flavio A Cadegiani; Claudio E Kater
Journal:  BMC Endocr Disord       Date:  2016-08-24       Impact factor: 2.763

8.  Childhood maltreatment interacts with hypothalamic-pituitary-adrenal axis negative feedback and major depression: effects on cognitive performance.

Authors:  Neus Salvat-Pujol; Javier Labad; Mikel Urretavizcaya; Aida de Arriba-Arnau; Cinto Segalàs; Eva Real; Alex Ferrer; José M Crespo; Susana Jiménez-Murcia; Carles Soriano-Mas; José M Menchón; Virginia Soria
Journal:  Eur J Psychotraumatol       Date:  2021-03-10

9.  The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.

Authors:  Tayfun Turan; Hasan Basri Izgi; Saliha Ozsoy; Fatih Tanrıverdi; Mustafa Basturk; Akif Asdemir; Aslı Beşirli; Ertugrul Esel; Seher Sofuoglu
Journal:  Psychiatry Investig       Date:  2009-06-23       Impact factor: 2.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.